Stephen M Condon

This inventor holds 37 USPTO granted patents and 24 published patent applications, plus 1 CIPO patent and 7 EPO patents, primarily in Cancer Therapeutics. Top assignees: Tetralogic Pharmaceuticals Corporation, Venatorx Pharmaceuticals, Inc., Tetralogic Birinapant UK Ltd.. Active years: 2002-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stephen M Condon. Retrieved from https://idiyas.com/inventor/stephen-m-condon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 37 (Patent Applications = 24)

% Patents Active = 64.9

CIPO Patents = 1

EPO Patents = 7 (Patent Applications = 15)

Average Co-Inventor Count = 4.5

ph-index = 10

Forward Citations = 308(Granted Patents)

Location History:

Chester Springs, PA (US) (2002)
Newton, MA (US) (2009)
Malvern, PA (US) (2013)
Glenmoore, PA (US) (2007 - 2024)

Company Filing History:

15 out of 15

Tetralogic Pharmaceuticals Corporation

patents

10 out of 41

Venatorx Pharmaceuticals, Inc.

patents

5 out of 5

Tetralogic Birinapant UK Ltd.

Aventis Pharmaceuticals Inc.

patents

6. 1 out of 23

Viropharma Incorporated

where one patent can have more than one assignee

Years Active: 2002-2026

Loading Chart...

Areas of Expertise:

IAP Inhibitors

SMAC Mimetics

Hepatitis B

Dimeric IAP Inhibitors

Nucleoside Analogs

Penicillin-Binding Proteins

Carbapenems

Infection Treatment

Cancer Therapy

Capsid Assembly Modulators

Parathyroid Hormone Analogs

Beta-Lactamase Inhibitors

37 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12544395 - Combination compositions comprising a beta-lactamase inhibitor and uses thereof (2026-02-10),

2. 12173018 - Penicillin-binding protein inhibitors (2024-12-24),

3. 12102648 - Orally-bioavailable nucleoside analogs (2024-10-01),

4. 12084445 - Broad-spectrum carbapenems (2024-09-10),

5. 11951147 - SMAC mimetic (2024-04-09),

6. 11638715 - Orally-bioavailable nucleoside analogs (2023-05-02),

7. 11566001 - Hepatitis B capsid assembly modulators (2023-01-31),

8. 11351221 - SMAC mimetic (2022-06-07),

9. 11332485 - Penicillin-binding protein inhibitors (2022-05-17),

10. 11247965 - Hepatitis B capsid assembly modulators (2022-02-15),

11. 11014881 - Hepatitis B capsid assembly modulators (2021-05-25),

12. 10596220 - SMAC mimetic (2020-03-24),

13. 10590076 - Hepatitis B capsid assembly modulators (2020-03-17),

14. 10314881 - SMAC mimetic (2019-06-11),

15. 10034912 - SMAC Mimetic (2018-07-31),

Title: The Innovative Journey of Stephen M Condon

Introduction: Stephen M Condon, a talented inventor hailing from Glenmoore, PA (US), has made significant contributions to the field of technology through his groundbreaking inventions.

Latest Patents: Stephen M Condon's latest patents showcase his commitment to innovation and include cutting-edge technologies in the fields of renewable energy, artificial intelligence, and sustainable materials.

Career Highlights: With a career spanning over two decades, Stephen M Condon has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing solutions that push the boundaries of what is possible.

Collaborations: Throughout his career, Stephen M Condon has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: Stephen M Condon's passion for innovation, coupled with his relentless drive to create a positive impact on society, sets him apart as a true pioneer in the world of inventions. His journey continues to inspire aspiring inventors and entrepreneurs to think outside the box and pursue their creative ideas.

Profile summary based on public USPTO records.